Lashaun McDowell-Esaw, APRN

Lashaun McDowell-Esaw practices at Millennium Physician Group in Venice, Florida.

Lashaun McDowell-Esaw's NPI, 1548041031, was assigned on October 10, 2023. Lashaun McDowell-Esaw holds Florida license APRN11028950.

Lashaun McDowell-Esaw's primary practice is Millennium Physician Group, at 1287 Us 41st S Byp, Venice, FL 34285 in Sarasota County. The practice phone is (877) 856-3774.

Lashaun McDowell-Esaw's primary practice is Millennium Physician Group in Venice, Florida. The medical group on file is Millennium Physician Group. Dmand AI also links Lashaun McDowell-Esaw to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Lashaun McDowell-Esaw practices. Vendor and product names are available with a free account.

Family is Lashaun McDowell-Esaw's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Lashaun McDowell-Esaw is licensed in Florida.

CMS data shows 142 Medicare services from Lashaun McDowell-Esaw across 5 procedure codes in 2024, for 79 Medicare patients. Medicare paid $9,082 for them. Every service was in an office.

CMS counts 79 Medicare patients who saw Lashaun McDowell-Esaw in 2024. The largest group is 75 to 84, with 35 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Lashaun McDowell-Esaw's median patient age at 67, with 59% women.

In 2024, Lashaun McDowell-Esaw wrote 577 Medicare Part D claims for 191 patients. 90% of them were for generic drugs. CMS names the drug for 281 of them, across 16 drugs with 11 or more claims each, at $2,141 in total drug cost.

Lashaun McDowell-Esaw accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Lashaun McDowell-Esaw as offering telehealth.

CMS Open Payments shows 85 general payments to Lashaun McDowell-Esaw from 21 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $400.